Item 2.02Results of Operations and Financial Condition.
bluebird bio, Inc. (the "Company" or "bluebird") intends to share with investors
the amount of cash, cash equivalents and marketable securities it had on hand as
of
Item 7.01Regulation FD Disclosure.
bluebird will be conducting meetings with investors attending the 38th Annual
The information in this Current Report on Form 8-K pursuant to Item 7.01 is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section. It may only be incorporated by reference in another filing under the Exchange Act or the Securities Act of 1933, as amended, if such subsequent filing specifically references the information furnished pursuant to Item 7.01 of this Current Report.
Item 8.01Other Events.
On
The full text of bluebird's press release regarding the announcement is filed as Exhibit 99.2 to this Current Report on Form 8K and is incorporated herein by reference.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 99.1 Slides presented to Investors furnished by bluebird bio, Inc. onJanuary 13, 2020 . 99.2 Press release issued by bluebird bio, Inc. onJanuary 13, 2020 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
--------------------------------------------------------------------------------
© Edgar Online, source